S&P 500

5.667,20

0,64%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Nightstar Therapeutics Plc ADS (NITE)
Nightstar Therapeutics Plc ADS (NITE) Notícias

NITE

Nightstar Therapeutics Plc ADS (NITE)

Nightstar Therapeutics Plc ADS

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:NITE

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
25/09/2018	17:22	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1)	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
25/09/2018	17:11	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
22/09/2018	12:57	GlobeNewswire Inc.	Nightstar Reports Positive Proof of Concept Data from Dose Escalation Study in XIRIUS Trial for NSR-RPGR in XLRP Patients	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
13/09/2018	07:05	GlobeNewswire Inc.	Nightstar Appoints Strategic Biotechnology Executive Paula Cobb to its Board of Directors	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
13/08/2018	07:05	GlobeNewswire Inc.	Nightstar Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
10/08/2018	11:01	Edgar (US Regulatory)	Schedule 13g	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
07/08/2018	18:28	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
07/08/2018	07:05	GlobeNewswire Inc.	Nightstar Therapeutics to Present at Wedbush PacGrow Healthcare Conference	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
14/06/2018	07:05	GlobeNewswire	Nightstar Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for NSR-REP1 in Choroideremia	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
06/06/2018	07:35	GlobeNewswire	Nightstar Therapeutics Reports First Quarter 2018 Financial Results and Acceleration of Preliminary NSR-RPGR Readout to Third...	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
31/05/2018	07:30	GlobeNewswire	Nightstar Therapeutics to Present at Jefferies 2018 Global Healthcare Conference	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
15/05/2018	16:00	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
02/05/2018	10:00	GlobeNewswire Inc.	Nightstar Therapeutics to Present at the Deutsche Bank 43rd Annual Health Care Conference	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
23/04/2018	07:30	GlobeNewswire	Nightstar Therapeutics to Present New Data in Choroideremia at the ARVO 2018 Annual Meeting	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
09/04/2018	13:59	Dow Jones News	Gene-Therapy Stocks Get Boost as Analysts Speculate Novartis' Next Target -- Market Mover	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
03/04/2018	18:36	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
03/04/2018	18:15	GlobeNewswire Inc.	Nightstar Therapeutics Reports 2017 Financial Results and Business Highlights	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
05/03/2018	08:30	GlobeNewswire	Nightstar Therapeutics Announces Initiation of STAR Phase 3 Registrational Trial for NSR-REP1 in Choroideremia	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
07/12/2017	09:30	GlobeNewswire	Nightstar Therapeutics to Participate in BMO Prescriptions for Success Healthcare Conference	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
08/11/2017	09:30	GlobeNewswire Inc.	Nightstar Expands Pipeline with Novel Gene Therapy for the Treatment of Stargardt Disease	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
30/10/2017	18:05	GlobeNewswire	Nightstar Therapeutics to Participate in Multiple Conferences in November	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
18/10/2017	18:39	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
06/10/2017	12:00	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
02/10/2017	17:05	GlobeNewswire	Nightstar Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Ameri...	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
02/10/2017	17:05	GlobeNewswire Inc.	Nightstar Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Ame...	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
28/09/2017	19:03	GlobeNewswire Inc.	Nasdaq Welcomes Nightstar Therapeutics Nightstar plc (Nasdaq: NITE) to The Nasdaq Stock Market	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
28/09/2017	07:00	GlobeNewswire Inc.	Nightstar Therapeutics (Nasdaq: NITE) to Ring The Nasdaq Stock Market Closing Bell in Celebration of Its IPO	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
27/09/2017	20:45	Business Wire	Nightstar Announces Pricing of Initial Public Offering	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
20/05/2010	17:03	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-A12B)	NASDAQ:NITE	Nightstar Therapeutics Plc ADS
20/05/2010	11:50	PR Newswire (US)	Knight Capital Group Comments on Contributions to Stabilize the U.S. Equity Markets in Response to the Plunge on May 6, 2010	NASDAQ:NITE	Nightstar Therapeutics Plc ADS